抓挠严重程度作为瘙痒客观评估的验证
目前缺乏简单标准化的瘙痒客观评估工具。该前瞻性门诊研究在261例成人特应性皮炎患者中验证抓挠严重程度(4级量表)与患者报告结局的相关性及纵向反应性。结果显示抓挠严重程度与整体疾病严重度、瘙痒数字评分及湿疹患者导向湿疹评分相关,且能反映随时间的变化。
要点
- 抓挠严重程度4级量表与特应性皮炎患者报告的瘙痒和疾病严重度相关。
- 抓挠严重程度改善≥1分者,过去3天瘙痒数字评分、5-D瘙痒量表和POEM评分显著更低。
- 抓挠严重程度或可作为瘙痒性疾病的临床试验终点,需在其他瘙痒性疾病中验证。
核心结论
- 抓挠严重程度可能是临床试验和实践中瘙痒性疾病的可用终点。
研究设计与样本
- 前瞻性门诊研究,纳入261例成人特应性皮炎患者,使用问卷和皮肤科医生评估。
主要发现
- 抓挠严重程度与患者报告的全球特应性皮炎严重度相关性最佳(Kendall τ=0.336,P<0.0001)。
- 抓挠严重程度与过去24小时瘙痒数字评分相关(τ=0.266,P=0.0010),与过去3天瘙痒数字评分相关(τ=0.296,P<0.0001)。
- 抓挠严重程度随时间显示反应性。
- 抓挠严重程度改善≥1分的患者,过去3天瘙痒数字评分显著更低(Wilcoxon秩和检验,P=0.0175),5-D瘙痒量表显著更低(P=0.0146),POEM评分显著更低(P=0.0146)。
- 过去3天瘙痒数字评分改善≥4分的患者,抓挠严重程度显著下降(Fisher精确检验,P=0.0026);POEM(P<0.0001)和DLQI(P=0.0285)也显示显著下降。
关键数值与推荐
- 抓挠严重程度采用4级序数量表:0=不存在,3=非常明显,基于抓挠病变观察。
临床怎么用
- 抓挠严重程度可作为临床实践中评估瘙痒的客观指标,尤其适用于特应性皮炎患者。
局限性
- 研究仅纳入成人特应性皮炎患者,需在其他瘙痒性疾病中进一步验证抓挠严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are currently no simple, standardized, objective assessments of itch for clinical trials and practice. We sought to validate and test the severity of scratching as an objective measure of itch (4-point ordinal scale ranging from 0 [not present] to 3 [very prominent] based on the observation of scratching lesions). We performed a prospective outpatient study using questionnaires and evaluations by a dermatologist in adults with atopic dermatitis (n = 261). Severity of scratching best correlated with patient-reported global atopic dermatitis severity (Kendall τ = 0.336, P < 0.0001), numeric rating scale of itch in the past 24 hours (τ = 0.266, P = 0.0010) and 3 days (τ = 0.296, P < 0.0001). Severity of scratching showed responsiveness over time. Patients experiencing improvement of scratching severity of 1 point or greater had significantly lower itch based on numeric rating scale in the past 3 days (Wilcoxon rank sum test, P = 0.0175), 5-D itch scale (P = 0.0146), and Patient-Oriented Eczema Measure scores (P = 0.0146). There was a significant decrease in scratching severity for patients experiencing itch improvement of 4 points or greater in the past 3 days on the numeric rating scale (Fisher exact test, P = 0.0026), Patient-Oriented Eczema Measure (P < 0.0001), and Dermatology Life Quality Index (P = 0.0285). Severity of scratching may be a useful endpoint in clinical trials and practice across the gamut of pruritic disorders. Future studies are needed to validate severity of scratching in other pruritic disease.
引用
- Udkoff J, Silverberg JI. Validation of Scratching Severity as an Objective Assessment for Itch. J Invest Dermatol. 2017. PMID: 29241681. doi:10.1016/j.jid.2017.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。